Urinary sulphated glycosaminoglycans and Tamm-Horsfall protein in type 1 diabetic patients

Scandinavian Journal of Urology and Nephrology

Volumn 33, Issue 5, 1999, Pages 328-332

  Torffvit, Ole ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Distal tubular function; Glycosaminoglycans; Tamm Horsfall protein

Indexed keywords

ALBUMIN; GLYCOSAMINOGLYCAN POLYSULFATE; HEMOGLOBIN A1C; TAMM HORSFALL GLYCOPROTEIN;

ADULT; ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; DISEASE ASSOCIATION; FEMALE; GLOMERULUS BASEMENT MEMBRANE; GLYCOSAMINOGLYCAN METABOLISM; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY TUBULE BASEMENT MEMBRANE; KIDNEY TUBULE DISORDER; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; PRIORITY JOURNAL; PROTEIN URINE LEVEL; PROTEINURIA; URINARY EXCRETION;

ALBUMINURIA; ANALYSIS OF VARIANCE; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; GLYCOSAMINOGLYCANS; HUMANS; KIDNEY; MUCOPROTEINS;

EID: 0032708359     PISSN: 00365599     EISSN: None     Source Type: Journal    
DOI: 10.1080/003655999750017428     Document Type: Article

References (27)

1. Van den Born J, van Kraats AA, Bakker MAH, Assmann KJM, van den Heuvel LPWJ, Veerkamp JH, et al. Selective proteinuria in diabetic nephropathy in the rat is associated with a relative decrease in glomerular basement membrane heparan sulphate. Diabetologia 1995; 38: 161-72.
2. Tamsma JT, Van den Born J, Bruijn JA, Assmann KJM, Weening JJ, Berden JHM, et al. Expression of glomerular extracellular matrix components in human diabetic nephropathy: decrease of heparan sulphate in the glomerular basement membrane. Diabetologia 1994; 37: 313-20.
3. Van den Born J, van Kraats AA, Bakker MAH, Assmann KJM, Dijkman HBPM, van der Laak JAWM, et al. Reduction of heparan sulphate-associated anionic sites in the glomerular basement membrane of rats with streptozotocin induced diabetic nephropathy. Diabetologia 1995; 38: 1169-75.
4. Reddi AS, Ramamurthi R, Miller M, Dhuper S, Lasker N. Enalapril improves albuminuria by preventing glomerular loss of heparan sulphate in diabetic rats. Biochem Med Metab Biol 1991; 45: 119-31.
5. Parthasarathy N, Spiro RG. Effect of diabetes on the glycosaminoglycan component of the human glomerular basement membrane. Diabetes 1982; 31: 738-41.
6. Wu V-Y, Wilson B, Cohen MP. Disturbances in glomerular basement membrane glycosaminoglycans in experimental diabetes. Diabetes 1987; 36: 679-83.
7. Vernier RL, Steffes MW, Sisson-Ross S, Mauer SM. Heparan sulphate proteoglycan in the glomerular basement membrane in type 1 diabetes mellitus. Kidney Int 1992; 41: 1070-80.
8. Seiler MW, Rennke HG, Venkatachalam MA, Cotran RS. Pathogenesis of polycation-induced alterations ("fusion") of glomerular epithelium. Lab Invest 1977; 36: 48-61.
9. 125I-bovine serum albumin. Lab Invest 1982; 47: 177-84.
10. Rasch R, Torffvit O, Bachmann S, Jensen PK, Jacobsen NO. Tamm-Horsfall glycoprotein in streptozotocin diabetic rats: a study of kidney in situ hybridization, immunohistochemistry, and urinary excretion. Diabetologia 1995; 38: 525-35.
11. Torffvit O, Agardh C-D. Urinary excretion rate of NC1 and Tamm-Horsfall protein in the microalbuminuric type I diabetic patient. J Diab Comp 1994; 8: 77-83.
12. Torffvit O, Jørgensen PE, Kamper A-L, Holstein-Rathlou N-H, Leyssac PP, Poulsen SS, et al. Urinary excretion of Tamm-Horsfall protein and epidermal growth factor in chronic nephropathy. Nephron 1998; 79: 167-72.
13. Couchman JR, Caterson B, Christner JE, Baker JR. Mapping by monoclonal antibody detection of glycosaminoglycans in connective tissue. Nature 1984; 307: 650-2.
14. Tencer J, Torffvit O, Björnsson S, Thysell H, Grubb A, Rippe B. Decreased excretion of glycosaminoglycans in patients with primary glomerular diseases. Clin Nephrol 1997; 48: 212-9.
15. Torffvit O, Wieslander J. A simplified enzyme-linked immunosorbent assay for urinary albumin. Scand J Clin Lab Invest 1986; 46: 545-8.
16. Torffvit O, Agardh C-D, Kjellsson B, Wieslander J. Tubular secretion of Tamm-Horsfall protein in type 1 (insulin-dependent) diabetes mellitus using a simplified enzyme linked immunoassay. Clin Chim Acta 1992; 205: 31-41.
17. Makino H, Ikeda S, Haramoto T, Ota Z. Heparan sulphate proteoglycans are lost in patients with diabetic nephropathy. Nephron 1992; 61: 415-21.
18. Wessler E. The nature of the non-ultrafilterable glycosaminoglycans of normal human urine. Biochem J 1971; 122: 373-84.
19. Sindelka G, Skrha J, Stibor V, Stolba P. Glycosaminoglycans in urine of type 1 diabetic patients. Sbornik Lekarsky 1993; 94: 77-80.
20. Hansen Ch, Irmscher AK, Kuhlemann K, Beyer J, Kahaly G. Insulin-dependent diabetes mellitus and glycosaminoglycans. Horm Metab Res 1955; 27: 555-8.
21. McAuliffe AV, Fisher EJ, McLennan SV, Yue DK, Turtle JR. Urinary glycosaminoglycan excretion in NIDDM subjects: its relationship to albuminuria. Diabetic Med 1996; 13: 758-63.
22. Priestly GC, Collier A, Matthews DM, Clarke BF. Increased urinary excretion of glycosaminoglycans in insulin-dependent diabetic patients with limited joint mobility. Br J Rheumatol 1988; 27: 462-4.
23. Mahadevan P, Larkins RG, Fraser JRE, Fosang AJ, Dunlop ME. Increased hyaluronan production in the glomeruli from diabetic rats: a link between glucose-induced prostaglandin production and reduced sulphated proteoglycan. Diabetologia 1995; 38: 298-305.
24. Bedir A, Özener IC, Adam B, Emerk K. Utility of glomerular and tubular markers in establishing early renal involvement in type II diabetes mellitus. Clin Biochem 1996; 29: 385-8.
25. Myrup B, Hansen PM, Jensen T, Kofoed-Enevoldsen A, Feldt-Rasmussen B, Gram J, et al. Effect of low-dose heparin on urinary albumin excretion in insulin-dependent diabetes mellitus. Lancet 1995; 345: 421-2.
26. Solini A, Ricci F, Vergnani L, Crepaldi G. Glycosaminoglycans delay the progression of nephropathy in NIDDM. Diabetes Care 1997; 20: 819-23.
27. Jyothirmayi G, Reddi AS. Effect of diltiazem on glomerular heparan sulfate and albuminuria in diabetic rats. Hypertension 1993; 21: 795-802.